# Open Label Immunotherapy of Endometriosis

> **NCT03340324** · PHASE2 · UNKNOWN · sponsor: **Immunitor LLC** · enrollment: 30 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **BIOLOGICAL:** V-Endo

## Key facts

- **NCT ID:** NCT03340324
- **Lead sponsor:** Immunitor LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340324, "Open Label Immunotherapy of Endometriosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03340324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*